Dublin-based biotech company TriMod Therapeutics Ltd has won €750,000 in initial seed capital to advance its research into innovative cancer treatments.
The results from research originally funded by Science Foundation Ireland will now be commercialised by the company, which was co-founded by a leading Trinity research academic, Kingston Mills, said a company statement on 6 December.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.